Phase 2 studies of adenosine cardioplegia

Circulation

Volumn 98, Issue 19 SUPPL., 1998, Pages

  Cohen, Gideon ^b   Feder Elituv, Randi ^b   Iazetta, John ^b   Bunting, Peter ^b   Mallidi, Hari ^b   Bozinovski, John ^b   Deemar, Cathy ^b   Christakis, George T ^b   Cohen, Eric A ^b   Wong, Bill I ^b   McLean, Richard D ^b   Myers, Martin ^b   Morgan, Christopher D ^b   Mazer, C David ^b   Smith, Terry S ^b   Goldman, Bernard S ^b   Naylor, C David ^b   Fremes, Stephen E ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b NONE

Author keywords

Adenosine; Bypass; Cardioplegia

Indexed keywords

ADENOSINE; HEART ENZYME; PLACEBO;

ADULT; ANGIOGRAPHY; ARTICLE; BLOOD SAMPLING; CARDIOPLEGIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG SAFETY; FEMALE; HEART PROTECTION; HUMAN; MALE; META ANALYSIS; OUTCOMES RESEARCH; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STIMULUS RESPONSE;

EID: 0345020464     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. 1 adenosine receptors in rabbit heart. Circulation. 1991;84:350-356.
2. Babbitt DG, Virmani R, Vildibill HD Jr, Norton ED, Forman MB. Intracoronary adenosine administration during reperfusion following 3 hours of ischemia: effects on infarct size, ventricular function, and regional myocardial blood flow. Am Heart J. 1990;120:808-818.
3. Toombs CF, McGee S, Johnston WE, Vinten-Johansen J. Myocardial protective effects of adenosine: infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation. 1992; 86:986-994.
4. Bolling SF, Bies LE, Bove EL, Gallagher KP. Augmenting intracellular adenosine improves myocardial recovery. J Thorac Cardiovasc Surg. 1990;99:469-474.
5. 1 receptor mechanism. Am J Physiol. 1992;263(pt 2):H1460-H1465.
6. Ledingham S, Katayama O, Lachno D, Patel N, Yacoub M. Beneficial effect of adenosine during reperfusion following prolonged cardioplegic arrest. Cardiovasc Res. 1990;24:247-253.
7. Ely SW, Mentzer RM, Lasley RD, Lee BK, Berne RM. Functional and metabolic evidence of enhanced myocardial tolerance to ischemia and reperfusion with adenosine. J Thorac Cardiovasc Surg. 1985;90: 549-556.
8. Pesikas D, Rocci MA, Bafflour R, de Varennes B, Symes J, Guerraty A. Enhanced 24 hour in-vitro heart preservation with adenosine and adenosine monophosphate. J Heart Transplant. 1990;9:114-118.
9. 1 selective adenosine analogues protects the heart against infarction. Circulation. 1992;85:659-665.
10. Urabe K, Miura T, Iwamoto T, Ogawa T, Goto M, Sakamoto J, Iimura O. Preconditioning enhances myocardial resistance to postischaemic myocardial stunning via adenosine receptor activation. Cardiovasc Res. 1993; 27:657-662.
11. Vander Heide RS, Reimer KA, Jennings RB. Adenosine slows ischemic metabolism in canine myocardium in vitro: relationship to ischemic preconditioning. Cardiovasc Res. 1993;27:669-673.
12. Hoshida S, Kuzuya T, Nishida M, Yamashita N, Oe H, Hori M, Kamada T, Tada M. Adenosine blockade during reperfusion reverses the infarct-limiting effect in preconditioned canine hearts. Cardiovasc Res. 1994;28: 1083-108.
13. Lee HT, Sanchala VT, Reed GE, Belkin RN, Lafaro RJ. Preconditioning of human myocardium with adenosine during cardiac surgery. Circulation. 1994;90(suppl I):I-48. Abstract.
14. Kerensky RA, Kutcher MA, Braden GA, Applegate RJ, Solis GA, Little WC. The effects of intracoronary adenosine on ischemia during coronary angioplasty. Clin Cardiol. 1995;18:91-96.
15. Hohlfeld T, Hearse DJ, Yellon DM, Isselhard W. Adenosine induced increase in myocardial ATP: are there beneficial effects for the ischemic myocardium? Basic Res Cardiol. 1989;84:499-509.
16. Hudspeth DA, Nakanishi K, Vinten-Johansen J, Zhao ZQ, McGee DS, Williams MW, Hammon JW Jr. Adenosine in blood cardioplegia prevents post-ischemic dysfunction in ischemically injured hearts. Ann Thorac Surg. 1994;58:1637-1644.
17. Bolling SF, Bies LE, Gallager KP, Bove EL. Enhanced myocardial protection with adenosine. Ann Thorac Surg. 1989;47:809-815.
18. Bolling SF, Bies LE, Bove EL. Effect of ATP synthesis promotors on postischemic myocardial recovery. J Surg Res. 1990;49:205-211.
19. Fremes SE, Levy SL, Christakis GT, Walker SE, lazetta J, Mallidi HR, Feder-Elituv R, Deemar KA, Cohen EA, Wong BI, Goldman BS. Phase I human trial of adenosine- potassium cardioplegia. Circulation. 1996; 94(suppl):II-370-II-375.
20. Warm Heart Trial Investigators. Normothermic versus hypothermic blood cardioplegia for coronary bypass surgery: a randomized trial in 1732 patients. Lancet. 1994;343:559-563.
21. Lichtenstein SV, Naylor CD, Feindel CM, Sykora K, Abel JG, Slutsky AS, Mazer CD, Christakis GT, Goldman BS, Fremes SE. Intermittent warm blood cardioplegia. Circulation. 1995;92(suppl II):II-341-II-346.
22. Pelletier LC, Carrier M, Leclerc Y, Cartier R, Wesolowska E, Solymoss BC. Intermittent antegrade warm versus cold blood cardioplegia: a prospective, randomized study, Ann Thorac Surg. 1994;58:41-48.
23. Burns RJ, Gladstone PJ, Tremblay PC, Feindel CM, Salter DR, Lipton IH, Ogilvie RR, David TE. Myocardial infarction determined by technetium-99m pyrophosphate single-photon tomography complicating elective coronary bypass grafting for angina pectoris. Am J Cardiol. 1989;63:1429-1434.
24. Christakis GT, Koch JP, Deemar KA, Frames SE, Sinclair L, Chen E, Salerno TA, Goldman BS, Lichtenstein SV. A randomized study of the systemic effects of warm heart surgery. Ann Thorac Surg. 1992;54: 449-459.
25. Christakis GT, Fremes SE, Koch JP, Harwood S, Sharpe E, Deemar KA, Hamilton C, Chen E, Rao V, Chang G, Goldman BS. Determinants of low systemic vascular resistance during cardiopulmonary bypass. Ann Thorac Surg. 1994;58:1040-1049.
26. Hodakowski GT, Craver JM, Jones EL, King SB III, Guyton RA. Clinical significance of perioperative Q-wave myocardial infarction: the Emory Angioplasty Versus Surgery Trial. J Thorac Cardiovasc Surg. 1996;112: 1447-1453.
27. Johnson MF. Issues in planning interim analyses. Drug Inform J. 1990; 24:361-370.
28. Armitage P. Interim analysis in clinical trials. Stars Med. 1991;10: 925-937.
29. Ikonomidis JS, Shirai T, Weisel RD, Derylo B, Rao V, Whitside CI, Mickle DA, Li RK. Preconditioning cultured human pediatric myocytes requires adenosine and protein kinase C. Am J Physiol. 1997;272:H1220-H1230.
30. Cohen G, Rao V, Weisel RD, Mohabeer MK, Noritsugu S, Borger MA, Carson SM, Ivanov J. Adenosine cardioplegia and myocardial metabolism. Circulation. 1997;97(suppl I):I-620-I-621.
31. Yau TM, Weisel RD, Mickle DA, Ivanov J, Mohabeer MK, Tumiati L, Carson S, Lichtenstein SV. Optimal delivery of blood cardioplegia. Circulation. 1991;84(suppl):III-380-III-388.
32. Yau TM, Weisel RD, Mickle DA, Komeda M, Ivanov J, Carson S, Mohabeer MK, Tumiati LC. Alternative techniques of cardioplegia. Circulation. 1992;86(suppl):II-377-II-384.
33. Yau TM, Ikonomidis JS, Weisel RD, Mickle DA, Hayashida N, Ivanov J, Carson S, Mohabeer MK, Tumiati LC. Which techniques of cardioplegia prevent ischemia? Ann Thorac Surg. 1993;56:1020-1028.
34. Cohen G, Shirai T, Weisel RD, Rao V, Merante F, Mickle DAG. Optimal preconditioning in a human model of ischemia and reperfusion. Circulation. 1997;96:I-299-I-300. Abstract.
35. Mentzer RM Jr, Rahko PS, Molina-Viamonte V, Canver CC, Chopra PS, Love RB, Cook TD, Hegge JO, Lasley RD. Safety, tolerance, and efficacy of adenosine as an additive to blood cardioplegia in humans during coronary artery bypass surgery. Am J Cardiol. 1997;79(12A): 38-43.
36. Vander Heide RS, Reimer KA. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs. Cardiovasc Res. 1996;31: 711-718.
37. Homeister JW, Hoff PT, Fletcher BA, Lucchesi BR. Combined adenosine and lidocaine administration limits myocardial reperfusion injury. Circulation. 1990;82:595-608.